A PROSPECTIVE STUDY OF SERUM FOLATE CONCENTRATION AND HEMOGLOBIN IN CERVIX CARCINOMA PATIENTS
Objective: The study aimed to have a prospective study of serum folate concentration and hemoglobin (Hb%) in cervical carcinoma patients.
Methods: The study was conducted on women suffering from carcinoma cervix. The research was conducted in the Gynecological Outpatient Department (OPD) of the Oncology Unit in Mahavir Cancer Sansthan Patna, Bihar. The study period was from May 2016 to April 2017. The sample was collected after face to face interview by Figo staging and the sample was taken regularly. As a result strong association of Hb% and carcinoma cervix was found with the mean value of lower than 11.12, which is lower than the normal range of Hb%. As per the further estimation of folic acid, the level of cervical cancer is low.
Results: The data were estimated with help of tools such as SPSS 16.0 and PRISMA 5.0. The Hb% the mean value of patients was estimated to be lower than 11.12, which is not under the normal range of Hb%, that is, nearly 12.5 mg/dl. The low mean value shows less Hb% content which leads to anemia in normal beings as well as in patients with cervical cancer. A strong association of Hb% which affected to patients in carcinoma cervix can be seen in the graph that the mean value of patients low 11.12±0.20 which not comes under normal range of Hb%, that is, 12.5 mg/dl. The R square value is 0.9556.
Conclusion: As per our study, we have estimated that the folic acid level in cervical cancer is low. The -normal range of folic acid level in plasma serum is 2.2–20 ug/ml. The mean of 20 control cases, new cervical cancer patients, on treating patients, and follow-up patients is 11.08, 2.206, 3.554, and 2.783, respectively. The control 11.08 shows the better level in plasma serum level comes under a normal range of folic acid level.
2. Arulogun OS, Maxwell OO. Perception and utilization of cervical cancer screening services among female nurses in University College Hospital, Ibadan, Nigeria. Pan Afr Med J 2012;11:69.
3. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet 2019;393:169-82.
4. Marquina G, Manzano A, Casado A. Targeted agents in cervical cancer: Beyond bevacizumab. Curr Oncol Rep 2018;20:40.
5. Suleiman M, Yanggau B. Risk Factors for Cervical Cancer: Diagnosis and Management; ???.
6. Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical cancer: A case-control study. Asia Pac J Oncol Nurs 2019;6:308-14.
7. Fotra RO, Gupta SH, Gupta S. Sociodemographic risk factors for cervical cancer in Jammu region of J and K state of India first ever report from Jammu. Indian J Sci Res 2014;9:105-10.
8. Petignat P, Roy M. Diagnosis and management of cervical cancer. BMJ 2007;335:765-8.
9. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health 2020;8:e191-203.
10. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
11. Fowler JR, Jack BW. Cancer Cervical. Treasure Island, FL: Stat Pearls Publishing; 2020.
12. Gangopadhyay A, Das J, Nath P, Biswas J. Haemoglobin levels may predict toxicities in patients on pelvic chemoradiation for carcinoma of the cervix-experience of a regional cancer centre. Ecancermedicalscience 2014;8:431.
13. Murphy JF. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. In: Vitamin and Mineral Nutrition Information System, (WHO/NMH/NHD/MNM/11.1.). Geneva: World Health Organization; 2011.
14. Tiwari KK, Gupta VK. A sensitive spectrophotometric method for the determination of ascorbic acid in biological and pharmaceutical samples. J Indian Counc Chem ???;25:112-6.
15. Crider KS, Yang TP, Berry RJ, Bailey LB. Folate and DNA methylation: A review of molecular mechanisms and the evidence for folate’s role. Adv Nutr 2012;3:21-38.
16. Gillet E, Meys JF, Verstraelen H, Verhelst R, de Sutter P, Temmerman M, et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: Systematic review and meta-analysis. PLoS One 2012;7:e45201.
17. Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz K. Risk factors and other epidemiologic considerations for cervical cancer screening: A narrative review for the US preventive services task force. Ann Intern Med 2011;55:698-705, W216.
18. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
19. Appleby P, Beral V, de González AB, Colin D, Franceschi S. International Collaboration of Epidemiological Studies of Cervical C. Carcinoma of the Cervix and Tobacco Smoking: Collaborative Reanalysis of Individual; 2006.
20. Lüthy J. Folate and the risk of colorectal, breast and cervix cancer: The epidemiological evidence. Swiss Med Wkly 2001;131:539-49.
21. Wang Z, Wang J, Fan J, Zhao W, Yang X, Wu L, et al. Risk factors for cervical intraepithelial neoplasia and cervical cancer in Chinese women: Large study in Jiexiu, Shanxi Province, China. J Cancer 2017;8:924-32.
22. Tellouche-Bouhouhou S, Chellat-Rezgoune D, Abadi N, Satta D, Dahdouh A. Methylenetetrahydrofolate reductase c677t gene polymorphism and prostate cancer risk. Asian J Pharm Clin Res 2018;11:387-9.
23. Pieroth R, Paver S, Day S, Lammersfeld C. Folate and its impact on cancer risk. Curr Nutr Rep 2018;7:70-84.
24. Zhao W, Hao M, Wang Y, Feng N, Wang Z, Wang W, et al. Association between folate status and cervical intraepithelial neoplasia. Eur J Clin Nutr 2016;70:837-42.
25. Pathak S, Bhatla N, Singh N. Cervical cancer pathogenesis is associated with one-carbon metabolism. Mol Cell Biochem 2012;369:1-7.
26. Zhou X, Meng Y. Association between serum folate level and cervical cancer: A meta-analysis. Arch Gynecol Obstet 2016;293:871-7.
27. Yang J, Yang A, Wang Z, Wang W, Wang Z, Wang Y, et al. Interactions between serum folate and human papillomavirus with cervical intraepithelial neoplasia risk in a Chinese population-based study Am J Clin Nutr 2017;108:1034-42.
28. Lu MH, Hu LY, Du XX, Yang M, Zhang WY, Huang K, et al. An special epithelial staining agents: Folic acid receptor-mediated diagnosis (FRD) effectively and conveniently screen patients with cervical cancer. Int J Clin Exp Med 2015;8:7830-6.
29. Hu D, Sheng Z, Fang S, Wang Y, Gao D, Zhang P, et al. Folate receptor-targeting gold nanoclusters as fluorescence enzyme mimetic nanoprobesfor tumor molecular colocalization diagnosis. Theranostics 2014;4:142-53.
30. Piyathilake CJ, Macaluso M, Alvarez RD, Bell WC, Heimburger DC, Partridge EE. Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient Vitamin B12 in the post-folic acid fortification era. Cancer Prev Res (Phila) 2009;2:658-64.
31. Tong SY, Kim MK, Lee JK, Lee JM, Choi SW, Friso S, et al. Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and Vitamin B12. Cancer Causes Control 2011;22:63-72.
32. Yeo AS, Schiff MA, Montoya G, Masuk M, van Asselt-King L, Becker TM. Serum micronutrients and cervical dysplasia in Southwestern American Indian women. Nutr Cancer 2000;38:141-50.
33. Wideroff L, Potischman N, Glass AG, Greer CE, Manos MM, Scott D, et al. A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix Nutr Cancer 1998;30:130-6.
34. Sekumade AI, Okunade KS, Olorunfemi G, Daramola EO, Adenekan MA, Okunowo AA, et al. Association between serum folate level and invasive cervical cancer at a university teaching hospital in South-West Nigeria. J Cancer Res Pract 2019;6:179-83.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.